FierceBiotech
Nov 19
In the next few weeks, Advanced Cell Technologies will file IND with the FDA for retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases. If the FDA signs off on ACT's trial, it will be only the second stem cell...